Equal access to medicines is one of the most pressing issues our generation must overcome. In response, we built our Axmed Platform - a pioneering marketplace designed to make high-quality, affordable medicines available in low- and middle-income countries. It leverages innovative technology to bridge the gap between manufacturers and the healthcare needs of developing regions. Partnering with Axmed allows organizations to tap into a comprehensive network of healthcare solutions designed to improve patient outcomes. We offer innovative data & analytics capabilities, strategic consultancy, and a commitment to making high-quality healthcare accessible to all. Our business model automizes demand consolidation at an unprecedented scale on the buying end. It leverages volume benefits for patients and healthcare providers, all the while expediting access to groundbreaking innovations by facilitating sustainable commercial approaches for pharmaceutical companies in markets where patient acquisition costs have prevented efficient access until today. Learn more about Axmed at axmed.com and remember, you can join the waitlist as we get ready for our Open Release on January 30th: https://lnkd.in/dshp2C7x 🚀 #MedicineAccess #B2BMarketplace #PharmaPartnerships #HealthTech #medicines
Axmed’s Post
More Relevant Posts
-
Patient centricity is increasingly recognized as essential in aligning healthcare with the real needs and preferences of those it serves. This approach underlines the importance of integrating patient perspectives into all phases of healthcare, from research to policy implementation. Despite advances in incorporating patient input into drug development and health assessments, ongoing challenges exist. Effective and early engagement of patients in the research process remains a key goal. The focus is on creating a healthcare environment where patient experiences and outcomes directly influence research and policy. Our aim is to build a system that genuinely listens to and acts upon the voices of patients, ensuring that patient-centricity is a practical reality in all aspects of healthcare. #HEOR #reimbursement #costeffectiveness #pharmaceuticals #HTA #marketacces #HealthEconomics #ISPOR #patientcentricity
To view or add a comment, sign in
-
When we think of healthcare, our minds often go straight to expenses—doctor visits, hospital bills, and pharmacy costs. But what if healthcare wasn’t just a cost but an opportunity? The healthcare sector is one of the most resilient and rapidly growing industries. Hospitals, diagnostic labs, and pharmaceutical companies aren’t just saving lives—they’re creating value for investors. So, it’s time to shift perspectives. Invest in healthcare stocks and watch your portfolio’s health improve right alongside the world’s well-being. After all, isn’t it time for your money to feel better too? To tap into the next big opportunity in healthcare, read our Initiating Coverage - Healthcare report now! Read Report: https://bit.ly/49yIsTY Disclaimer: bit.ly/45Bhbyn #AxisDirect #SimpleHai #healthcaresector #InvestmentInsights #StockMarket #healthcare #StockMarketInvesting #StockMarketAnalysis #InformedInvesting #StockMarketIndia #hospital #health
To view or add a comment, sign in
-
Pharma and Healthcare companies ar gearing up for busy 2024 . Dive deeper into our M and A trends in our Mid year outlook. #Pharma and #healthcare companies are eager to get deals done as they grow more comfortable navigating the current environment of elevated interest rates and regulatory pressure. Read more: https://pwc.to/4eqaovd #PwCDeals #IndustryTrends
To view or add a comment, sign in
-
On #WorldHealthDay, Raptim Research reaffirms its dedication to the fundamental principle: 'My Health, My Right'. Let's empower individuals worldwide to take charge of their health journey. 🌍💪 #HealthForAll #MyHealthMyRight"
On #WorldHealthDay, Raptim Research stands firm in its commitment to promoting 'My Health My Right'. As a CRO dedicated to advancing healthcare and pharmaceutical services, we're reaffirming our commitment to global wellness. We believe everyone deserves access to quality healthcare. Externally we support E2E clinical research for global pharma R&D for a healthier world, and internally, we prioritize the health and well-being of our employees, ensuring a healthier world starts within. Let's work together towards a brighter, healthier future for all! #HealthForAll #MyHealthMyRight #EmployeeWellness #ClinicalResearch
To view or add a comment, sign in
-
In the dynamic landscape of provider practices, increasing consolidation is reshaping the industry. Healthcare systems, payers, and private equity are swiftly acquiring formerly independent practices, altering ownership structures and influencing provider priorities and accessibility. This consolidation also impacts prescribing patterns, pressuring manufacturers for discounts via providers. Standardized care protocols are emerging under unified ownership and altering treatment decisions driven by financial incentives. Vertical integration further enhances this trend, fostering better medical benefit oversight. Providers, key to accessibility, face challenges in adapting to evolving standards and financial constraints. To regain control, they're implementing operational models, necessitating pharmaceutical companies to strategize localized pricing to minimize redundancies and maximize efficiency. #Healthcare #Pharma #PayerProviderRelationship #Pharmaceuticals
To view or add a comment, sign in
-
🌟 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐧𝐠 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐟𝐨𝐫 𝐌𝐢𝐥𝐥𝐢𝐨𝐧𝐬 🌟 Nearly 40% of Germany’s population live with a #chronicDisease. At the apo.com Group, we’re tackling this challenge by combining modern #healthTech with compassionate pharmaceutical counseling to ensure better access to medication and personalized care. 💊💻 Our scalable solutions streamline processes and enhance accessibility, creating impactful change for those who need it most. By bridging technology and healthcare, we’re setting new standards for smarter, more inclusive care. 🌐✨ Watch this video to find out more about our mission: https://lnkd.in/e4bbsJJi #HealthcareInnovation #DigitalHealth #PharmaTech
To view or add a comment, sign in
-
How can healthcare providers and medtech companies forge win-win partnerships that benefit both sides? At the EPP Life Sciences Pricing Forum 2024, join Raphael Prync from Medtronic for a thought-provoking session on Outcome-Based Tendering and Risk Sharing. This session will dive into the principles of innovative tenders vs. traditional tenders, exploring how these new models can bring significant benefits for healthcare providers while offering unique advantages for MedTech companies. In today’s fast-evolving healthcare landscape, outcome-based tendering and risk-sharing strategies are becoming essential for delivering better patient outcomes and optimizing costs. If you want to understand how these partnerships can drive success for your organization, this is a session you won’t want to miss! Download the event brochure to get more details! https://lnkd.in/d2KYzBZX #EPP #EPPLSPF #LSF24 #LifeSciences #Pharma #Biopharma #Medtech #PricingStrategies #Innovation #Healthcare #LifeSciences2024
To view or add a comment, sign in
-
Are you ready to elevate your engagement with Integrated Delivery Networks (IDNs)? Our latest white paper is your essential guide. Discover how IDNs operate, what they expect from pharma partners, and the best strategies for pre-launch engagement. Don’t miss out on these insights to drive impactful collaborations and enhance patient outcomes. Download your copy today: https://ow.ly/UyVZ50TLXny. Christopher Nuesch Renu Kondragunta #Healthcare #Pharma #IDNs #Partnerships #WhitePaper #PatientOutcomes
To view or add a comment, sign in
-
“Donald Trump’s Return: What’s Next for Healthcare in the GCC?” With Donald Trump returning to office, what changes can we expect in healthcare across the GCC? Will his focus on cost reduction and privatization drive positive change? Could we see more U.S.-GCC collaborations in medical tech, pharmaceuticals, and healthcare infrastructure? How might these partnerships reshape healthcare delivery in the region? Will Trump’s policies on drug pricing, transparency, and regulatory burdens impact healthcare strategies in the GCC? Can the region find a balance between cost-efficiency and quality care? What do you think? Will Trump’s policies benefit healthcare in the GCC, or are the challenges too great? #HealthcareInnovation #GCCHealthcare #HealthcareStrategy #GlobalPartnerships #MedicalTech #MiddleEastHealthcare #FutureOfHealthcare #HealthPolicy #HealthcareReform #MedicalCollaboration #HealthTech #DigitalHealth #Telemedicine #PatientCare #SustainableHealthcare #HealthcareLeadership #Pharmaceuticals #HealthEconomics #HealthcareTransformation #AffordableHealthcare #HealthcareGrowth #DigitalTransformation #HealthEquity #MedicalTechnology
To view or add a comment, sign in
-
New Case Study Alert from CMI Media Group and PulsePoint! 🌧️🌡️ A leading pharmaceutical company leveraged real-time weather data to reach healthcare professionals (HCPs) in areas experiencing cold weather. The innovative campaign demonstrated significant results! Discover how this cutting-edge approach optimized HCP engagement and drove prescribing behavior: https://lnkd.in/etTgaAsj. The Weather Company #CaseStudy #HCPengagement #HCPmarketing #HealthInnovation #HealthMarketing #WeatherTargeting
To view or add a comment, sign in
7,852 followers